DE1203271B - Process for the preparation of new 2-mercapto-imidazole derivatives and their salts - Google Patents
Process for the preparation of new 2-mercapto-imidazole derivatives and their saltsInfo
- Publication number
- DE1203271B DE1203271B DEG42062A DEG0042062A DE1203271B DE 1203271 B DE1203271 B DE 1203271B DE G42062 A DEG42062 A DE G42062A DE G0042062 A DEG0042062 A DE G0042062A DE 1203271 B DE1203271 B DE 1203271B
- Authority
- DE
- Germany
- Prior art keywords
- radical
- carbon atoms
- maximum
- group
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 5
- 150000003839 salts Chemical class 0.000 title claims description 5
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical class SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 title claims description 4
- -1 cyano, nitro, amino Chemical group 0.000 claims description 27
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 8
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 239000011541 reaction mixture Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- 229910000037 hydrogen sulfide Inorganic materials 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 150000003141 primary amines Chemical class 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- XSOGCNFUHPRKKS-UHFFFAOYSA-N 3-(4-methoxyphenyl)-4-methyl-2-sulfanylidene-1H-imidazole-5-carboxylic acid Chemical compound COC1=CC=C(C=C1)N1C(=NC(=C1C)C(=O)O)S XSOGCNFUHPRKKS-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QSLPNSWXUQHVLP-UHFFFAOYSA-N $l^{1}-sulfanylmethane Chemical compound [S]C QSLPNSWXUQHVLP-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NKWCGTOZTHZDHB-UHFFFAOYSA-N 1h-imidazol-1-ium-4-carboxylate Chemical class OC(=O)C1=CNC=N1 NKWCGTOZTHZDHB-UHFFFAOYSA-N 0.000 description 1
- BHWMORLQDQSWHP-UHFFFAOYSA-N 3-(4-methoxyphenyl)-4-methyl-1h-imidazole-2-thione Chemical compound C1=CC(OC)=CC=C1N1C(S)=NC=C1C BHWMORLQDQSWHP-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- SBQPDLGIWJRKBS-UHFFFAOYSA-N 4-methyl-1,3-dihydroimidazole-2-thione Chemical compound CC1=CNC(S)=N1 SBQPDLGIWJRKBS-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- NAHLXTSXDXHVKU-UHFFFAOYSA-N CCOC(C(N=C1S)=C(C)N1C(C=CC=C1)=C1OC)=O Chemical compound CCOC(C(N=C1S)=C(C)N1C(C=CC=C1)=C1OC)=O NAHLXTSXDXHVKU-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000530268 Lycaena heteronea Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- JGIATAMCQXIDNZ-UHFFFAOYSA-N calcium sulfide Chemical compound [Ca]=S JGIATAMCQXIDNZ-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- HIRGQGZZYOYRGV-UHFFFAOYSA-N chloroform;pentane Chemical compound ClC(Cl)Cl.CCCCC HIRGQGZZYOYRGV-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- HXCKCCRKGXHOBK-UHFFFAOYSA-N cycloheptane Chemical compound [CH]1CCCCCC1 HXCKCCRKGXHOBK-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- DPLVEEXVKBWGHE-UHFFFAOYSA-N potassium sulfide Chemical compound [S-2].[K+].[K+] DPLVEEXVKBWGHE-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000005853 β-dimethylaminoethyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von neuen 2-Mereapto-imidazol-derivaten und ihren Salzen Die Erfindung betrifft ein Verfahren zur Herstellung von neuen 2-Mercaptoimidazolderivaten der allgemeinen Formel I in der R1 ein Wasserstoffatom, eine Methyl-, Carboxy-oder Carbalkoxygruppe und R2 einen Alkylrest mit höchstens 10 Kohlenstoffatomen, einen Alkenylrest mit höchstens 6 Kohlenstoffatomen, einen Cycloalkylrest mit höchstens 7 Kohlenstoffatomen, einen u),ci-Dialkoxyalkylenrest mit höchstens 6 Kohlenstoff atomen, eine Dialkylaminoalkylgruppe mit insgesamt höchstens 10 Kohlenstoffatomen, in der die beiden Alkylreste zusammen mit dem Stickstoffatom auch zu einem 5- bis 7gliedrigen Alkyleniminorest verbunden sein können, eine Phenyl- oder eine Phenylalkylengruppe mit höchstens 4 Kohlenstoffatomen im Alkylenrest, wobei die Phenyl- und die Phenylalkylengruppe durch Halogenatome, die Hydroxy-, Cyano-, Nitro-, Amino-trifiuormethyl-, Acetoxy-, Carboxy-oder Carbäthoxygruppe, einen niederen Alkylthio-oder einen niederen Alkanoylrest mit höchstens 4 Kohlenstoffatomen oder 1 bis 3 niedere Alkyl- oder Alkoxyreste mit höchstens 4 Kohlenstoffatomen substituiert sein können, bedeuten, und ihren Salzen, das dadurch gekennzeichnet ist, daß man Formaldehyd mit primären Aminen der allgemeinen Formel II R2 - NH2 (II) und mit a-Isonitrosoketonen der allgemeinen Formel III in der R1' einen Methyl- oder Carbalkoxyrest bedeutet, in Gegenwart von Lösungsmitteln umsetzt, das erhaltene Reaktionsgemisch mit Schwefelwasserstoff bzw. Ammonium-, Alkali- oder Erdalkalimetallsulfiden oder -hydrosulfiden behandelt, gegebenenfalls die erhaltenen Reaktionsprodukte in an sich bekannter Weise verseift, anschließend decarboxyliert und die erhaltenen Basen mit Säuren umsetzt. Vorzugsweise werden Natriumsulfid, Kaliumsulfid, Calciumsulfid oder Ammoniumsulfid verwendet. Zur Verseifung der 4-Carbalkoxyimidazole werden diese vorzugsweise in wäßrigen Lösungen von Alkalimetallhydroxyden suspendiert bzw. gelöst. Die Decarboxylierung der erhaltenen 4-Carboxyimidazolderivate kann durch einfaches Erhitzen derselben bis zur Schmelztemperatur oder auch unter Verwendung von hochsiedenden tertiären Aminen, wie Chinolin als Lösungsmittel, und von Metallkatalysatoren, z. B. Kupferpulver, durchgeführt werden.Process for the production of new 2-mercaptoimidazole derivatives and their salts The invention relates to a process for the production of new 2-mercaptoimidazole derivatives of the general formula I in which R1 is a hydrogen atom, a methyl, carboxy or carbalkoxy group and R2 is an alkyl radical with a maximum of 10 carbon atoms, an alkenyl radical with a maximum of 6 carbon atoms, a cycloalkyl radical with a maximum of 7 carbon atoms, a u), ci-dialkoxyalkylene radical with a maximum of 6 carbon atoms, a dialkylaminoalkyl group with a total of at most 10 carbon atoms, in which the two alkyl radicals together with the nitrogen atom can also be linked to form a 5- to 7-membered alkyleneimino radical, a phenyl or a phenylalkylene group with a maximum of 4 carbon atoms in the alkylene radical, the phenyl and phenylalkylene groups through Halogen atoms, the hydroxy, cyano, nitro, amino-trifluoromethyl, acetoxy, carboxy or carbethoxy group, a lower alkylthio or a lower alkanoyl radical with a maximum of 4 carbon atoms or 1 to 3 lower alkyl or alkoxy radicals with a maximum of 4 carbon atoms can be substituted, mean, and their salts, there s is characterized in that formaldehyde with primary amines of the general formula II R2 - NH2 (II) and with a-isonitrosoketones of the general formula III in which R1 'denotes a methyl or carbalkoxy radical, reacts in the presence of solvents, treats the resulting reaction mixture with hydrogen sulfide or ammonium, alkali or alkaline earth metal sulfides or hydrosulfides, optionally saponifying the resulting reaction products in a manner known per se, then decarboxylating and the bases obtained are reacted with acids. Sodium sulfide, potassium sulfide, calcium sulfide or ammonium sulfide are preferably used. To saponify the 4-carbalkoxyimidazoles, these are preferably suspended or dissolved in aqueous solutions of alkali metal hydroxides. The decarboxylation of the 4-carboxyimidazole derivatives obtained can be carried out by simply heating them to the melting temperature or using high-boiling tertiary amines such as quinoline as solvents and metal catalysts, e.g. B. copper powder.
In den Verbindungen der allgemeinen Formell ist R2 beispielsweise ein Alkylrest wie der Methyl-, Äthyl-, n-Propyl-, Isopropyl-, n-Butyl-, a-Äthylpropyl-, oc-Methyl-butyl-, n-Hexyl- oder n-Octylrest, ein Alkenylrest, vorzugsweise der Allylrest, ein Cycloalkylrest, wie der Cyclopentyl-, Cyclohexyl- oder Cycloheptylrest, ein w,co-Dialkoxyalkylenrest, wie der Dimethoxymethyl-, ß,ß-Dimethoxyäthyl, ß,ß-Diäthoxyäthyl- odery,y-Dimethoxypropylrest, ein Dialkylaminoalkylrest, wie der Dimethylaminomethyl-, Diäthylaminomethyl-, ß-Dimethylaminoäthyl-, ß-Diäthylaminoäthyl-, y-Dimethylaminopropyl- oder y-Diäthylaminopropylrest sowie ein N-ß-Pyrrolidinyläthyl-, ,B-Piperidinoäthyl- oder ß-Hexamethyleniminoäthylrest, ein Phenylalkylenrest, wie der Benzyl-, ß-Phenyläthyl-, ß-Phenylisopropyl- oder y-Phenylpropylrest oder ein Phenylrest. Diese Phenylalkylen- oder Phenylreste können einen der folgenden Ringsubstituenten tragen: Halogenatome, wie Fluor, Chlor oder Brom, die Hydroxy-, Cyano-, Nitro-, Amino-, Trifluormethyl-, Acetoxy-, Carboxy- oder die Carbäthoxygruppe, ferner einen niederen Alkylthiorest, vorzugsweise den Methylthiorest oder einen niederen Alkanoylrest, vorzugsweise den Acetylrest. Ferner können die Phenylalkylen- oder Phenylreste 1 bis 3 niedere Alkylgruppen, vorzugsweise die Methylgruppe oder niedere Alkoxygruppen, vorzugsweise die Methoxy- oder Äthoxygruppetragen.For example, in the compounds of the general formula, R2 is an alkyl radical such as methyl, ethyl, n-propyl, isopropyl, n-butyl, a-ethylpropyl, oc-methyl-butyl, n-hexyl or n-octyl radical, an alkenyl radical, preferably the allyl radical, a cycloalkyl radical such as the cyclopentyl, cyclohexyl or cycloheptyl radical w, co-dialkoxyalkylene radical, such as dimethoxymethyl, ß, ß-dimethoxyethyl, ß, ß-diethoxyäthyl ory, y-dimethoxypropyl radical, a dialkylaminoalkyl radical, such as dimethylaminomethyl, Diethylaminomethyl, ß-dimethylaminoethyl, ß-diethylaminoethyl, y-dimethylaminopropyl or γ-diethylaminopropyl radical as well as an N-ß-pyrrolidinylethyl, , B-piperidinoethyl or ß-hexamethyleneiminoethyl radical, a phenylalkylene radical, such as the benzyl, ß-phenylethyl, ß-phenylisopropyl or γ-phenylpropyl radical or a Phenyl radical. These phenylalkylene or phenyl radicals can have one of the following ring substituents carry: halogen atoms, such as fluorine, chlorine or bromine, the hydroxy, cyano, nitro, Amino, trifluoromethyl, acetoxy, carboxy or the carbethoxy group, and also one lower alkylthio radical, preferably the methylthio radical or a lower alkanoyl radical, preferably the acetyl radical. Furthermore, the phenylalkylene or phenyl radicals 1 up to 3 lower alkyl groups, preferably the methyl group or lower alkoxy groups, preferably carry the methoxy or ethoxy group.
Durch die Behandlung mit anorganischen oder organischen Säuren, wie Salzsäure, Bromwasserstoff säure, Schwefelsäure, Phosphorsäure, Methansulfonsäure, Äthandisulfonsäure, ß-Hydroxyäthansulfonsäure, Essigsäure, Bernsteinsäure, Fumarsäure, Maleinsäure, Äpfelsäure, Weinsäure, Citronensäure, Benzoesäure, Salicylsäure und Mandelsäure werden die 2-Mereaptoimidazolbasen in Salze, welche zum Teil wasserlöslich sind, übergeführt.By treatment with inorganic or organic acids, such as Hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulfonic acid, Ethane disulphonic acid, ß-hydroxyethane sulphonic acid, acetic acid, succinic acid, fumaric acid, Maleic acid, malic acid, tartaric acid, citric acid, benzoic acid, and salicylic acid Mandelic acid, the 2-mereaptoimidazole bases are converted into salts, some of which are water-soluble are convicted.
Die Verfahrensprodukte besitzen wertvolle pharmakologische Eigenschaften. Sie haben analgetische, beruhigende, sedative und muskelrelaxierende Wirksamkeit auf Grund ihrer dämpfenden Wirkung auf das Zentralnervensystem.The products of the process have valuable pharmacological properties. They have analgesic, calming, sedative and muscle relaxing effects due to their dampening effect on the central nervous system.
Ferner weisen sie antipyretische und antiinflammatorische Eigenschaften auf.They also have antipyretic and anti-inflammatory properties on.
Die nachfolgenden Beispiele erläutern die Erfindung. Die Temperaturen sind in Celsiusgraden angegeben. Beispie11 a) 10,0 ml einerwäßrigenFormaldehydlösung(37 °/o) und 12,32 g p-Anisidin werden in 30 ml Äthanol gegeben. Nach 3 Minuten hat sich ein schwerer Niederschlag gebildet, 15,9 g Isonitrosoacetessigester werden daraufhin hinzugefügt, das Gemisch wird unter Rückfluß erhitzt, und ein starker Schwefelwasserstoff strom wird während einer Stunde hindurchgeleitet. Daraufhin wird die Reaktion abgebrochen und das Gemisch auf 5° abgekühlt. Nach Umkristallisieren des entstandenen Niederschlags aus Äthanol und anschließend aus Chloroform-Pentanwerden 13 g(45 °/o) 1-(p-Methoxyphenyl)-2-mercapto-4-carbäthoxy-5-methylimidazol erhalten, Schmp. 203 bis 205°.The following examples illustrate the invention. The temperatures are given in degrees Celsius. Example 11 a) 10.0 ml of an aqueous formaldehyde solution (37%) and 12.32 g of p-anisidine are added to 30 ml of ethanol. After 3 minutes a heavy precipitate has formed, 15.9 g of isonitrosoacetoacetic ester are then added, the mixture is heated to reflux and a vigorous stream of hydrogen sulfide is passed through it for one hour. The reaction is then terminated and the mixture is cooled to 5 °. After recrystallization of the precipitate formed from ethanol and then from chloroform-pentane, 13 g (45%) 1- (p-methoxyphenyl) -2-mercapto-4-carbethoxy-5-methylimidazole are obtained, melting point 203-205 °.
b) 27,8 g 1-(Methoxyphenyl)-2-mercapto-4-carbäthoxy-5-methyl-imidazol werden mit 500 ml 3 n-NaOH 1 Stunde unter Rückfluß gekocht. Nach dem Abkühlen und Filtrieren wird das Filtrat angesäuert und der Niederschlag auf einem Büchnertrichter gesammelt. Nach dem Umkristallisieren aus Dioxan wird das 1-(p-Methoxyphenyl)-2-mercapto-4-carboxy-5-methylimidazol in 97 °/o Ausbeute erhalten; Schmp. 265° (Zersetzung).b) 27.8 g of 1- (methoxyphenyl) -2-mercapto-4-carbethoxy-5-methyl-imidazole are refluxed with 500 ml of 3N NaOH for 1 hour. After cooling down and Filtration, the filtrate is acidified and the precipitate on a Buchner funnel collected. After recrystallization from dioxane, the 1- (p-methoxyphenyl) -2-mercapto-4-carboxy-5-methylimidazole is obtained obtained in 97% yield; Mp. 265 ° (decomposition).
c) 10,70 g 1-(p-Methoxyphenyl)-2-mercapto-4-carboxy-5-methyl-imidazol werden in einem Metallbad 7 Minuten auf 277' erhitzt. Eine starke COZ-Entwicklung setzt ein und läßt schnell wieder nach. Das Produkt wird gekühlt und kristallisiert sofort. Der abgekühlte Rückstand wird aus Äthanol-Äther umkristallisiert und das 1-(p-Methoxyphenyl)-2-mercapto-5-methyl-imidazol in 63 °/o Ausbeute erhalten; Schmp. 226 bis 230°. Beispie12 a) Zur Lösung von 11,1 g p-Fluoranilin in 50 ml Äthanol werden 10 ml wäßrige Formaldehydlösung (37 °/o) gegeben. Die Mischung wird 30 Minuten am Rückfluß gekocht und dann abgekühlt. Eine Lösung von 16,0 g Isonitrosoacetessigester in 25 ml Äthanol und eine Lösung von 75 g Natriumhydrosulfid in einer möglichst geringen Menge Wasser werden gleichzeitig zugegeben. Das Reaktionsgemisch wird 4 Stunden am Rückfluß gekocht, dann wird nochmals eine konzentrierte wäßrige Lösung von 20 g Natriumhydrosulfid zugegeben und weitere 10 Stunden am Rückfiuß gekocht. Die Reaktionsmischung wird abgekühlt und der Niederschlag abfiltriert. Zum Filtrat werden 200 ml Wasser zugegeben und das organische Lösungsmittel im Vakuum abdestilliert.c) 10.70 g of 1- (p-methoxyphenyl) -2-mercapto-4-carboxy-5-methyl-imidazole are heated to 277 'in a metal bath for 7 minutes. A strong COZ development sets in and quickly subsides again. The product is cooled and immediately crystallizes. The cooled residue is recrystallized from ethanol-ether and the 1- (p-methoxyphenyl) -2-mercapto-5-methyl-imidazole is obtained in 63% yield; M.p. 226 to 230 °. Example 12 a) 10 ml of aqueous formaldehyde solution (37%) are added to the solution of 11.1 g of p-fluoroaniline in 50 ml of ethanol. The mixture is refluxed for 30 minutes and then cooled. A solution of 16.0 g of isonitrosoacetoacetic ester in 25 ml of ethanol and a solution of 75 g of sodium hydrosulfide in the smallest possible amount of water are added at the same time. The reaction mixture is refluxed for 4 hours, then another concentrated aqueous solution of 20 g of sodium hydrosulfide is added and refluxed for a further 10 hours. The reaction mixture is cooled and the precipitate is filtered off. 200 ml of water are added to the filtrate and the organic solvent is distilled off in vacuo.
b) Die zurückbleibende wäßrige Phase wird durch Zugabe von 50 ml 3 n-NaOH alkalisch gestellt und auf dem Dampfbad erhitzt, bis alles in Lösung gegangen ist.b) The remaining aqueous phase is by adding 50 ml of 3 Make n-NaOH alkaline and heat it on the steam bath until everything has gone into solution is.
c) Nach Abkühlen wird die Reaktionsmischung mit $n-HCl ausgesäuert und erwärmt. Nachdem die Entwicklung von Schwefelwasserstoff und Kohlendioxyd aufgehört hat, wird das Reaktionsgemisch gekühlt und mit Butanol und Chloroform extrahiert. Die zusammengegebenen organischen Phasen werden über Magnesiumsulfat getrocknet und filtriert. Die Lösungsmittel werden im Vakuum abdestilliert und der Rückstand aus Methanol-Äthanol umkristallisiert. Das erhaltene 1-(p-Fluorphenyl)-2-mereapto-5-methylimidazol schmilzt bei 265 bis 268'. Beispiel 3 Aus dem gemäß den Beispielen 1 und 2 hergestellten 1-(o)-Diäthylaminoäthyl)-2-mercapto-5-methylimidazol wird wie folgt das Hydrochlorid hergestellt: Zu einer Lösung von 3,0 g 1-(co-Diäthylarninoäthyl)-2-mercapto-5-methyl-imidazol wird die stöchiometrische Menge 2n-äthanolischer Salzsäure gegeben. Die Mischung wird 20 Minuten bei Zimmertemperatur belassen. Dann wird das Lösungsmittel bei 12 Torr und 50° abdestilliert. Der Rückstand wird in 15 ml heißem Isopropanol gelöst; beim Abkühlen scheidet sich das kristalline Hydrochlorid ab; Schmp. 186 bis 188°.c) After cooling, the reaction mixture is acidified with $ n-HCl and heated. After the evolution of hydrogen sulfide and carbon dioxide has ceased, the reaction mixture is cooled and extracted with butanol and chloroform. The combined organic phases are dried over magnesium sulfate and filtered. The solvents are distilled off in vacuo and the residue is recrystallized from methanol-ethanol. The 1- (p-fluorophenyl) -2-mereapto-5-methylimidazole obtained melts at 265 to 268 '. Example 3 The hydrochloride is prepared as follows from the 1- (o) -diethylaminoethyl) -2-mercapto-5-methylimidazole prepared according to Examples 1 and 2: To a solution of 3.0 g of 1- (co-diethylaminoethyl) - The stoichiometric amount of 2N ethanolic hydrochloric acid is added to 2-mercapto-5-methyl-imidazole. The mixture is left at room temperature for 20 minutes. Then the solvent is distilled off at 12 torr and 50 °. The residue is dissolved in 15 ml of hot isopropanol; the crystalline hydrochloride separates out on cooling; 186 to 188 °.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1203271XA | 1962-06-22 | 1962-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1203271B true DE1203271B (en) | 1965-10-21 |
Family
ID=22389563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEG42062A Pending DE1203271B (en) | 1962-06-22 | 1963-06-21 | Process for the preparation of new 2-mercapto-imidazole derivatives and their salts |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1203271B (en) |
-
1963
- 1963-06-21 DE DEG42062A patent/DE1203271B/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2936705A1 (en) | NEW 4-ANILINOQUINAZOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM | |
| US2831027A (en) | Isocamphane compounds and processes for preparing the same | |
| DE2461802C2 (en) | Pyrazine carboxamide derivatives | |
| DE2511891A1 (en) | Anti-thrombotic dioxo-piperazine derivs - prepd. e.g. by cyclising N,N,N',N'-1,2-alkylene-diamine-tetraacetic acids with amines | |
| DE2458638C2 (en) | 4'-substituted 2-methyl-3-piperidinopropiophenone derivatives, processes for their production and pharmacological preparations which contain them | |
| DE1909110A1 (en) | Process for the preparation of new heterocyclic compounds | |
| DE1816993C3 (en) | Process for the preparation of indolyl-3-acetic acids | |
| DE2534962C3 (en) | cis-3,4-ureylenethiophane-l, l-dioxide and process for its preparation | |
| DE1203271B (en) | Process for the preparation of new 2-mercapto-imidazole derivatives and their salts | |
| EP0025501B1 (en) | N-aminoalkyl indole derivatives and their salts, processes for their preparation and medicaments containing these compounds | |
| DE1203269B (en) | Process for the preparation of imidazolone-2-derivatives and their salts | |
| DE2142792A1 (en) | Heterocyclic compounds | |
| DE2151487A1 (en) | Pharmaceutical masses | |
| EP0113911B1 (en) | Pyrido-triazoloquinazolines, their preparation and use | |
| AT236946B (en) | Process for the preparation of new mercapto-imidazole derivatives | |
| DE1190951B (en) | Process for the preparation of N- (2, 3-dimethylphenyl) anthranilic acid and salts thereof | |
| DE2051871A1 (en) | Beta-amino-alpha-aryloxymethylacrylonitrile - and 2,4-diamino-5-benzylpyrimidine derivs. useful as antibacterial agents | |
| DE850297C (en) | Process for the preparation of amidine salts | |
| EP0102929B1 (en) | Propylamine derivatives, process for their preparation, pharmaceutical compositions containing these compounds, and their therapeutical use | |
| DE60001615T2 (en) | Process for the preparation of trisubstituted oxazoles | |
| DE1470120C3 (en) | 1 square bracket to 1- (3-benzoylpropyl) -4-piperidyl square bracket to - and 1 square bracket to 1- (3-benzoylpropyl) -1,2,5,6-tetrahydro-4pyridyl square bracket to -2-benzimidazolinone derivatives. their acid addition salts and processes for their preparation | |
| DE1745780C3 (en) | l-Sulfonyläthyl ^ -methyl-S-nitroimidazole and process for their preparation | |
| AT226710B (en) | Process for the preparation of new dihydroquinoxalones (2) and their salts | |
| AT237614B (en) | Process for the preparation of new imidazole derivatives | |
| CH438308A (en) | Process for the preparation of new isoquinoline compounds |